{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"condition":["Colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2688354"],"location":["China"],"study_start_month":["11"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A prospective, non-interventional, multicenter clinical study to explore  the efficacy and safety of camrelizumab in combination with regorafenib in patients with advanced colorectal cancer","description":"Interventions: Case series:Drug intervention\nPrimary outcome(s): PFS\nStudy Design: Single arm","dates":{"creation":"2019-11-15"},"accession":"2688354","cross_references":{"Chinese Clinical Trial Register":["ChiCTR1900027398"]}}